U.S. Markets open in 11 mins

Gene Therapy Battle: Why Sangamo Therapeutics Is Thrashing Its Rivals

ALLISON GATLIN
Gene Therapy Battle: Why Sangamo Therapeutics Is Thrashing Its Rivals

Sangamo stock popped Monday after the biotech company unveiled promising results for its Pfizer-partnered gene therapy in hemophilia A treatment. Sangamo stock jumped as much as 16.9%.